Delivery Order SPE2DB24D2106-SPE2DB25FAVYX
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,114.52 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this contract at its facility in Park Ridge. The delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and no set-aside designation was...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine syringes (0.5mL) under a firm fixed-price contract. This delivery order, valued at $13,922.86 with an ultimate completion date of July 21, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $21,878.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform this work at its Park Ridge facility and deliver the...
- This is a $28,696.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the BOOSTRIX TDAP vaccine syringe, 0.5 mL, with a completion date of June 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 27, 2025, by the Defense Logistics Agency for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract carries a ceiling value of $17,048.40 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. No set-aside designation was utilized for this award, and the place of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,815.90 firm fixed-price contract is for the procurement of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a pharmaceutical product, with a period of performance ending on January 17, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the BOOSTRIX TDAP VACCINE VIAL 0.5ML. This order, valued at $2,790.70, is part of a larger indefinite delivery contract that DMS Pharmaceutical Group holds with the Defense Logistics Agency to supply a variety of pharmaceutical items and medical supplies, including medications, vaccines, and other products, to support military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,059.42 contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to support the medical supply needs of military health facilities. DMS Pharmaceutical Group has a significant single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 with the DLA under the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,136.56 for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. It is a firm fixed-price contract with an ultimate completion date of April 14, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,195,547 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a ceiling value of $4,782.78. The contract is a firm fixed-price delivery order with an ultimate completion date of October 23, 2024. DMS Pharmaceutical Group Inc. holds a significant...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAVYXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,064.40 to DMS Pharmaceutical Group Inc. for Boostrix TDAP vaccine in syringe form (0.5ML) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is positioned as a critical supplier within the federal pharmaceutical supply chain through its extensive contracting relationships with the Defense Logistics Agency. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which holds a potential value of $499,999,999 and extends through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products, including biologics, vaccines, and medical consumables to support medical supply needs across Department of Defense healthcare facilities worldwide. The Boostrix TDAP vaccine delivery order represents a routine pharmaceutical supply replenishment within this broader contractual framework that has consistently demonstrated the contractor's capability to deliver specialized pharmaceutical products to military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/11/25 |